Memantine trial for cognitive impairment in multiple scleros
Posted: Fri May 28, 2010 7:17 am
Abstract
Background: Memantine, an NMDA antagonist, is effective for moderate to severe Alzheimer's disease.
Objective: Determine whether memantine improves cognitive performance (CP) among subjects with multiple ... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1264